De novo activating KIT mutations typically occur in one of 4 exons: exon 11 (67% of all GIST, including non-KIT-mutated GIST), exon 9 (10%), 13 (1%), and 17 (1%).21-23. Here, KIT is linked to gastrointestinal stromal tumor.